Watson Sues FDA for Failing to Grant Shared Exclusivity for Actos Generic

Washington Drug Letter
A A
Watson Pharmaceuticals is suing the FDA after it failed to grant the company shared exclusivity on a generic of Type 2 diabetes drug Actos.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00